sumatriptan

FDA Drug Profile — sumatriptan, IMITREX, SUMATRIPTAN, TOSYMRA, Sumatriptan

sumatriptan is listed in the FDA National Drug Code directory with 43 NDC codes, marketed under brand names including sumatriptan, IMITREX, SUMATRIPTAN. Available dosage forms: injection, solution, injection, spray, tablet, film coated.

Drug details

Generic Name
sumatriptan
Brand Names
sumatriptan, IMITREX, SUMATRIPTAN, TOSYMRA, Sumatriptan
Application Number
ANDA090314
Sponsor
ONESOURCE SPECIALTY PHARMA LIMITED
NDC Codes
43
Dosage Forms
INJECTION, SOLUTION, INJECTION, SPRAY, TABLET, FILM COATED
Routes
SUBCUTANEOUS, NASAL, ORAL
Active Ingredients
SUMATRIPTAN SUCCINATE, SUMATRIPTAN

Indications and Usage

1 INDICATIONS AND USAGE Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan, reconsider the diagnosis of migraine before sumatriptan is administered to treat any subsequent attacks. • Sumatriptan is not indicated for the prevention of migraine attacks. • Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. (1) • Not indicated for the prophylactic therapy of migraine attacks. (1) • Not indicated for the treatment of cluster headache. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.